One concern associated with coronavirus vaccines is the possibility that anti-S-protein antibodies could promote infection of cells, such as alveolar macrophages, expressing Fc receptors, for example FcγRI (CD64) or FcγRII (CD32). Here, FCGR1A is linked to infection.